Aiforia Technologies Oyj (FRA:L6J)
| Market Cap | 43.74M -56.6% |
| Revenue (ttm) | 3.54M +23.9% |
| Net Income | -12.67M |
| EPS | -0.41 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 1.082 |
| Previous Close | 1.094 |
| Day's Range | 1.082 - 1.082 |
| 52-Week Range | 1.000 - 3.300 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |
About Aiforia Technologies Oyj
Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology... [Read more]
Financial Performance
In 2025, Aiforia Technologies Oyj's revenue was 3.54 million, an increase of 23.95% compared to the previous year's 2.85 million. Losses were -12.67 million, 6.01% more than in 2024.
Financial StatementsNews
Aiforia Technologies Oyj: Inside information, profit warning: Aiforia's revenue developed below the estimates during January-June 2026
Aiforia Technologies Plc, Company release, Inside information, July 21, 2026 at 6:40 p.m. EEST Inside information, profit warning: Aiforia's revenue developed below the estimates during January-Jun...
Aiforia Technologies Oyj Earnings Call Transcript: H2 2025
Revenue grew 24% year-over-year, with clinical sector up 68% and accelerating in H2. Investments in AI and regulatory compliance drove portfolio expansion, while recurring revenue and major wins in Europe and the U.S. support scale-up ambitions.
Aiforia Technologies Oyj Annual report: H2 2025
Aiforia Technologies Oyj has published its H2 2025 annual report on March 6, 2026.
Aiforia Technologies Oyj Quarterly report: H2 2025
Aiforia Technologies Oyj has published its H2 2025 quarterly earnings report on March 6, 2026.
Aiforia Technologies Oyj Slides: H2 2025
Aiforia Technologies Oyj has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 6, 2026.
Aiforia Technologies Oyj Earnings Call Transcript: H1 2025
Order book grew 58% year-over-year, with clinical revenue up 60% and major European customer wins. Revenue was flat overall due to timing of deliveries, but strong pipeline and regulatory progress position the company for accelerated growth in H2 and beyond.
Aiforia Technologies Oyj Quarterly report: H1 2025
Aiforia Technologies Oyj has published its H1 2025 quarterly earnings report on August 28, 2025.
Aiforia Technologies Oyj Slides: H1 2025
Aiforia Technologies Oyj has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 28, 2025.